These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 17505170)

  • 1. Sealing the left atrial appendage: ready for prime time?
    El-Chami MF; Hoffman M; Lerakis S
    Am J Med Sci; 2007 May; 333(5):285-9. PubMed ID: 17505170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Le D; Morelli R; Badhwar N; Lee RJ
    Expert Rev Cardiovasc Ther; 2015; 13(8):907-14. PubMed ID: 26070218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial appendage occlusion for stroke prevention.
    Alli OO; Holmes DR
    Curr Probl Cardiol; 2015 Oct; 40(10):429-76. PubMed ID: 26382881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: ready for the prime time?
    Tzikas A; Freixa X; Ibrahim R
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1587-9. PubMed ID: 24215187
    [No Abstract]   [Full Text] [Related]  

  • 6. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention in atrial fibrillation: atrial appendage closure.
    Fuller CJ; Reisman M
    Curr Cardiol Rep; 2011 Apr; 13(2):159-66. PubMed ID: 21225480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial).
    Main ML; Fan D; Reddy VY; Holmes DR; Gordon NT; Coggins TR; House JA; Liao L; Rabineau D; Latus GG; Huber KC; Sievert H; Wright RF; Doshi SK; Douglas PS
    Am J Cardiol; 2016 Apr; 117(7):1127-34. PubMed ID: 26993976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Bajwa RJ; Kovell L; Resar JR; Arbab-Zadeh A; Mandal K; Calkins H; Berger RD
    Clin Cardiol; 2017 Oct; 40(10):825-831. PubMed ID: 28750152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
    Syed TM; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage exclusion: state-of-the-art.
    Cruz-Gonzalez I; Yan BP; Lam YY
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):806-13. PubMed ID: 20088009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical closure devices for atrial fibrillation.
    Price MJ; Holmes DR
    Trends Cardiovasc Med; 2014 Aug; 24(6):225-31. PubMed ID: 25066488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience.
    Abelson M
    Cardiovasc J Afr; 2013 May; 24(4):107-9. PubMed ID: 24217039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to left atrial appendage exclusion: the WATCHMAN device.
    Gorodnitskiy A; Lucariello RJ; Aizer A; Coppola JT
    Cardiol Rev; 2010; 18(5):230-3. PubMed ID: 20699670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.
    Alli O; Doshi S; Kar S; Reddy V; Sievert H; Mullin C; Swarup V; Whisenant B; Holmes D
    J Am Coll Cardiol; 2013 Apr; 61(17):1790-8. PubMed ID: 23500276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.
    Möbius-Winkler S; Schuler GC; Sick PB
    Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
    Onalan O; Crystal E
    Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage closure is preferred to chronic warfarin therapy: the pro perspective.
    Atoui M; Gunda S; Lakkireddy D
    Card Electrophysiol Clin; 2015 Sep; 7(3):403-13. PubMed ID: 26304519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual leaks following percutaneous left atrial appendage occlusion: assessment and management implications.
    Raphael CE; Friedman PA; Saw J; Pislaru SV; Munger TM; Holmes DR
    EuroIntervention; 2017 Nov; 13(10):1218-1225. PubMed ID: 28691914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.